Long-Term Therapy with a Depot Luteinizing Hormone-Releasing Hormone Analogue (Zoladex) in Patients with Advanced Prostatic Carcinoma-Reference-Cited by-同舟云学术

Long-Term Therapy with a Depot Luteinizing Hormone-Releasing Hormone Analogue (Zoladex) in Patients with Advanced Prostatic Carcinoma

Published:1988-10 Issue:4 Volume:140 Page:775-777
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Debruyne Frans M.J.¹²³⁴⁵,Denis Louis¹²³⁴⁵,Lunglmayer Gerhart¹²³⁴⁵,Mahler Charles¹²³⁴⁵,Newling Don W.W.¹²³⁴⁵,Richards Brian¹²³⁴⁵,Robinson Mell R.G.¹²³⁴⁵,Smith Philip H.¹²³⁴⁵,Weil Ernest H.J.¹²³⁴⁵,Whelan Peter¹²³⁴⁵

Affiliation:

1. From the Departments of Urology, Sint Radboud University Hospital, Nijmegen and St. Annadal University Hospital, Maastricht, The Netherlands

2. A. Ö. Hospital, Mistelbach, Austria

3. Princess Royal Hospital, Hull

4. York District Hospital, York

5. Pontefract General Infirmary, Pontefract and St. James’ University Hospital, Leeds, United Kingdom

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference12 articles.

1. Results of a Dutch phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer;Debruyne,1985

2. An LH-RH analogue (zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections;Robinson;Eur. J. Surg. Oncol.,1985

3. Longterm therapy with depot LHRH analogue (Zoladex) in patients with advanced prostate cancer;Denis,1987

4. Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone;Kerle;Brit. Med. J.,1984

5. Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetate;Schröder;J. Urol.,1987

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinically established biodegradable long acting injectables: An industry perspective;Advanced Drug Delivery Reviews;2020-12

2. Drug Formulations: How these Affects Anticancer Drug;Cancer Drug Discovery and Development;2013-11-30

3. Synthesis and in vitro cellular evaluation of novel anti-tumor norcantharidin-conjugated chitosan derivatives;International Journal of Biological Macromolecules;2013-11

4. Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt;Advanced Drug Delivery Reviews;2009-11

5. Encapsulation of Indomethacin Using Coaxial Ultrasonic Atomization Followed by Solvent Evaporation;Drug Development and Industrial Pharmacy;2008-01